{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:06:00Z","timestamp":1788278760339,"version":"build-2803163510"},"reference-count":84,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background\/objectives: Gestational trophoblastic diseases (GTDs) are rare premalignant and malignant conditions characterized by abnormal proliferation of trophoblastic tissue. They are often asymptomatic but may present with vaginal bleeding. GTDs include hydatidiform moles and gestational trophoblastic neoplasms (GTNs). Current research aims to improve diagnostic tools and treatment strategies to reduce cancer risk and improve survival. Increasing attention is being paid to immunotherapy and treatment personalization, with the goal of minimizing long-term side effects and enhancing quality of life. Less toxic therapies are ideal for low-risk patients to reduce drug-related toxicity. Materials and Methods: A narrative review was conducted to analyze studies from the last twenty years on the diagnosis, staging, and treatment of GTDs. Sources included PubMed, Scopus, and Cochrane Library, using keywords such as \u201ctrophoblastic disease,\u201d \u201chydatidiform mole,\u201d and \u201cgestational trophoblastic neoplasia.\u201d Results: In recent years, the clinical management of gestational trophoblastic disease (GTD) has made significant progress through diagnostic, prognostic, and therapeutic innovations. More sensitive imaging techniques and serial monitoring of serum \u03b2-hCG now allow early diagnosis of hydatidiform mole and gestational trophoblastic neoplasia (GTN), reducing the risk of complications and metastasis. Conclusions: In the last decade, GTD management has improved significantly, with better diagnostic techniques, standardized staging, and more effective treatments. However, challenges persist, including relapse management, long-term monitoring, and psychological support. Early diagnosis is key, with ultrasound being essential for detecting abnormalities in the first weeks of pregnancy. Staging follows FIGO and WHO criteria, considering hCG levels and metastasis. This review highlights recent advances in diagnostic tools, emerging therapies\u2014including immunotherapy\u2014and the need for personalized, less toxic treatment approaches to improve patient outcomes.<\/jats:p>","DOI":"10.3390\/medicina61091642","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T12:27:41Z","timestamp":1757507261000},"page":"1642","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gestational Trophoblastic Disease: Diagnostic and Therapeutic Updates in Light of Recent Evidence: A Literature Review"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4269-4269","authenticated-orcid":false,"given":"Giuseppe","family":"Gullo","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, AOOR Villa Sofia\u2013Cervello, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin\u00ec","family":"Satullo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, AOOR Villa Sofia\u2013Cervello, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Conti","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, AOOR Villa Sofia\u2013Cervello, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ganduscio","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, AOOR Villa Sofia\u2013Cervello, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9225-8030","authenticated-orcid":false,"given":"Elena","family":"Chitoran","sequence":"additional","affiliation":[{"name":"General Surgery and Surgical Oncology Department I, Bucharest Institute of Oncology, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7485-9895","authenticated-orcid":false,"given":"Zoltan","family":"Kozinszky","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Szeged, 6725 Szeged, Hungary"},{"name":"Capio Specialized Center for Gynecology, Solna, 182 88 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9276-4563","authenticated-orcid":false,"given":"Karolina","family":"Kowalcze","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Faculty of Medicine, Academy of Silesia, Rolna 43, 40-555 Katowice, Poland"},{"name":"Department of Pediatrics in Bytom, Faculty of Health Sciences in Katowice, Medical University of Silesia, Stefana Batorego 15, 41-902 Bytom, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-2620","authenticated-orcid":false,"given":"Robert","family":"Krysiak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Billone","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, AOOR Villa Sofia\u2013Cervello, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspare","family":"Cucinella","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, AOOR Villa Sofia\u2013Cervello, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/AOG.0000000000004240","article-title":"Gestational Trophoblastic Disease: Current Evaluation and Management","volume":"137","author":"Soper","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.hoc.2024.07.003","article-title":"Epidemiology of Gestational Trophoblastic Disease","volume":"38","author":"Joneborg","year":"2024","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1470-2045(03)01245-2","article-title":"Epidemiology and aetiology of gestational trophoblastic diseases","volume":"4","author":"Altieri","year":"2003","journal-title":"Lancet Oncol."},{"key":"ref_4","first-page":"103","article-title":"The epidemiology of gestational trophoblastic disease","volume":"143","author":"Parazzini","year":"1997","journal-title":"Gen. Diagn. Pathol."},{"key":"ref_5","first-page":"EC27","article-title":"Gestational Trophoblastic Disease\u2014Clinicopathological Study at Tertiary Care Hospital","volume":"11","author":"Jagtap","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/AOG.0b013e3181802186","article-title":"Maternal age-related rates of gestational trophoblastic disease","volume":"112","author":"Altman","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.47162\/RJME.66.1.01","article-title":"Gestational trophoblastic diseases\u2014Literature review and atypical case reports","volume":"66","author":"Vrabie","year":"2025","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: Epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/01.AOG.0000147669.68914.f6","article-title":"Practice bulletin No. 53\u2014Diagnosis and treatment of gestational trophoblastic disease","volume":"104","author":"Kohorn","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajog.2018.10.024","article-title":"Interstitial pregnancy mimicking an invasive hydatidiform mole","volume":"220","author":"Mittal","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.12688\/f1000research.14953.1","article-title":"Understanding and management of gestational trophoblastic disease","volume":"8","author":"Ning","year":"2019","journal-title":"F1000Res"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet"},{"key":"ref_13","unstructured":"Bruce, S., and Sorosky, J. (2025). Gestational trophoblastic disease. StatPearls, StatPearls Publishing."},{"key":"ref_14","unstructured":"Cue, L., Farci, F., Ghassemzadeh, S., and Kang, M. (2025). Hydatidiform Mole. StatPearls, StatPearls Publishing."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.radi.2022.06.005","article-title":"The diagnostic value and accuracy of ultrasound in diagnosing hydatidiform mole: A systematic review and meta-analysis of the literature","volume":"28","author":"Newhouse","year":"2022","journal-title":"Radiography"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/uog.22134","article-title":"ISUOG Practice Guidelines: Diagnosis and management of small-for-gestational-age fetus and fetal growth restriction","volume":"56","author":"Lees","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143","author":"Ngan","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0029-7844(95)00268-V","article-title":"The changing clinical presentation of complete molar pregnancy","volume":"86","author":"Bernstein","year":"1995","journal-title":"Obstet. Gynecol."},{"key":"ref_19","first-page":"1","article-title":"Hydatidiform mole: Diagnosis, management and long-term follow-up of 347 patients","volume":"45","author":"Curry","year":"1975","journal-title":"Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kurman, R.J., Ellenson, L.H., and Ronnett, B.M. (2011). Diagnostic histopathology of hydatidiform moles and gestational trophoblastic tumors. Blaustein\u2019s Pathology of the Female Genital Tract, Springer. [6th ed.].","DOI":"10.1007\/978-1-4419-0489-8"},{"key":"ref_21","first-page":"148","article-title":"Immunohistochemical expression of BCL-2 in hydatidiform moles: A tissue microarray study","volume":"1","author":"Arafa","year":"2023","journal-title":"Pathologica"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/AOG.0000000000002232","article-title":"Practice Bulletin No. 181: Prevention of Rh D Alloimmunization","volume":"130","author":"Silver","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"ref_23","first-page":"A5082","article-title":"Gestational trophoblastic diseases\u2014Clinical guidelines for diagnosis, treatment, follow-up, and counselling","volume":"62","author":"Niemann","year":"2015","journal-title":"Dan. Med. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1055\/s-0035-1558054","article-title":"Gestational Trophoblastic Disorders: An Update in 2015","volume":"75","author":"Stevens","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1471-0528.2007.01320.x","article-title":"Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: Evidence for revised protocol of a UK regional trophoblastic disease unit","volume":"114","author":"Sebire","year":"2007","journal-title":"BJOG"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.hoc.2024.07.001","article-title":"Diagnosis and Management of Molar Pregnancies","volume":"38","author":"Braga","year":"2024","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"vi39","DOI":"10.1093\/annonc\/mdt345","article-title":"Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Seckl","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zhao, P., Lu, Y., Tong, B., and Lu, V.V. (2019). Total hysterectomy versus uterine evacuation for preventing post-molar gestational trophoblastic neoplasia in patients who are at least 40 years old: A systematic review and meta-analysis. BMC Cancer, 19.","DOI":"10.1186\/s12885-018-5168-x"},{"key":"ref_29","first-page":"546","article-title":"Management of twin pregnancies consisting of a complete hydatidiform mole and normal fetus","volume":"91","author":"Fishman","year":"1998","journal-title":"Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2017.01.021","article-title":"Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review","volume":"145","author":"Lin","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/humrep\/15.3.608","article-title":"Hydatidiform mole coexistent with a twin fetus: A national collaborative study in Japan","volume":"15","author":"Matsui","year":"2000","journal-title":"Hum. Reprod."},{"key":"ref_32","unstructured":"(2000). WHO Prognostic Scoring System for GTN, as Adapted by FIGO, WHO."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2478\/raon-2022-0038","article-title":"Advances in diagnostics and management of gestational trophoblastic disease","volume":"56","author":"Lukinovic","year":"2022","journal-title":"Radiol. Oncol."},{"key":"ref_34","first-page":"806256","article-title":"Current chemotherapeutic management of patients with gestational trophoblastic neoplasia","volume":"2011","author":"May","year":"2011","journal-title":"Chemother. Res. Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/0002-9378(90)90907-O","article-title":"Diagnostic and therapeutic curettage in gestational trophoblastic disease","volume":"162","author":"Schlaerth","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2005.06.032","article-title":"The curative effect of a second curettage in persistent trophoblastic disease: A retrospective cohort survey","volume":"99","author":"Massuger","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2004.08.045","article-title":"The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease","volume":"95","author":"Pezeshki","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.6004\/jnccn.2019.7364","article-title":"State-of-the-Art Workup and Initial Management of Newly Diagnosed Molar Pregnancy and Postmolar Gestational Trophoblastic Neoplasia","volume":"17","author":"Elias","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2008.11.003","article-title":"Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia","volume":"112","author":"Growdon","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12094-017-1793-0","article-title":"SEOM clinical guidelines in gestational trophoblastic disease (2017)","volume":"20","author":"Santaballa","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.1997.15.7.2636","article-title":"EMA\/CO for high-risk gestational trophoblastic tumors: Results from a cohort of 272 patients","volume":"15","author":"Bower","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1525-1438.2007.00999.x","article-title":"EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: A clinical analysis of 54 patients","volume":"18","author":"Lu","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/1471-0528.17374","article-title":"Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis","volume":"130","author":"Albright","year":"2023","journal-title":"BJOG"},{"key":"ref_44","first-page":"767","article-title":"Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy","volume":"51","author":"Lurain","year":"2006","journal-title":"J. Reprod. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2003.08.028","article-title":"Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy","volume":"91","author":"Escobar","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"ref_46","first-page":"e35195","article-title":"Invasive Mole Mimicking Abnormal Uterine Bleeding: A Case Report","volume":"15","author":"Sankhe","year":"2023","journal-title":"Cureus"},{"key":"ref_47","first-page":"205","article-title":"Unusual presentation of invasive mole: A case report","volume":"18","author":"Aminimoghaddam","year":"2017","journal-title":"J. Reprod. Infertil."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/ijgc-2023-004704","article-title":"Gestational choriocarcinoma","volume":"33","author":"Bogani","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2021.02.005","article-title":"Pathology of gestational trophoblastic disease (GTD)","volume":"74","author":"Kaur","year":"2021","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_50","first-page":"256","article-title":"Update on the diagnosis and management of placental site trophoblastic tumor and epithelioid trophoblastic tumor","volume":"35","author":"Cheng","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_51","first-page":"e1","article-title":"Management of gestational trophoblastic disease","volume":"128","author":"Tidy","year":"2021","journal-title":"BJOG"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"401.e1","DOI":"10.1016\/j.ajog.2021.05.006","article-title":"Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7,761 patients in France","volume":"225","author":"Descargues","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bpobgyn.2020.10.004","article-title":"Placental site trophoblastic tumour and epithelioid trophoblastic tumour","volume":"74","author":"Hancock","year":"2021","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/ijgc-2018-000028","article-title":"Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe?","volume":"29","author":"Frijstein","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ejca.2015.05.026","article-title":"Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseases","volume":"51","author":"Bolze","year":"2015","journal-title":"Eur. J. Cancer."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1200\/JCO-24-02326","article-title":"Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD)\u2013European Society of Gynaecologic Oncology (ESGO)\u2013Gynecologic Cancer InterGroup (GCIG)\u2013International Society for the Study of Trophoblastic Diseases (ISSTD)","volume":"43","author":"Lok","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jogc.2020.03.001","article-title":"Guideline No. 408: Management of Gestational Trophoblastic Diseases","volume":"43","author":"Eiriksson","year":"2021","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1590\/0100-69912017001009","article-title":"The role of surgery in the management of women with gestational trophoblastic disease","volume":"44","author":"Lima","year":"2017","journal-title":"Rev. Col. Bras. Cir."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2021.10.003","article-title":"Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: A Society of Gynecologic Oncology evidenced-based review and recommendation","volume":"163","author":"Horowitz","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Sasaki, S., Sasaki, Y., Kunimura, T., Sekizawa, A., Kojima, Y., and Iino, K. (2015). Clinical Usefulness of Immunohistochemical Staining of p57 kip2 for the Differential Diagnosis of Complete Mole. Biomed. Res. Int., 2015.","DOI":"10.1155\/2015\/905648"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/GCO.0000000000000674","article-title":"Treatment of gestational trophoblastic disease in the 2020s","volume":"33","author":"Clark","year":"2021","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ygyno.2018.05.030","article-title":"First-line hysterectomy for women with low-risk non-metastatic gestational trophoblastic neoplasia no longer wishing to conceive","volume":"150","author":"Bolze","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000533972","article-title":"Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm","volume":"89","author":"Baas","year":"2024","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","article-title":"Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia","volume":"390","author":"Ghorani","year":"2017","journal-title":"Lancet"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Liu, X., Li, X., Qu, H., Zhang, S., Zhang, R., and Du, Z. (2022). Effectiveness and Safety of Toripalimab Combination Therapies for Patients with Chemo-Resistant Choriocarcinoma. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.815917"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S1470-2045(21)00460-5","article-title":"Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): A single-arm, open-label, phase 2 trial","volume":"22","author":"Cheng","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ygyno.2022.11.005","article-title":"Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trial","volume":"168","author":"You","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1016\/S1470-2045(21)00525-8","article-title":"Immunotherapy for cancer treatment during pregnancy","volume":"22","author":"Borgers","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ijgc-2022-003771","article-title":"Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy","volume":"33","author":"Hennah","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"100625","DOI":"10.1016\/j.gore.2020.100625","article-title":"Successful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: A case for immune checkpoint salvage therapy in trophoblastic tumors","volume":"34","author":"Clair","year":"2020","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.humpath.2018.10.001","article-title":"Analysis of PD-L1 expression in trophoblastic tissues and tumors","volume":"84","author":"Lu","year":"2019","journal-title":"Hum. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/his.13882","article-title":"PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia","volume":"75","author":"Zong","year":"2019","journal-title":"Histopathology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"LBA6008","DOI":"10.1200\/JCO.2020.38.18_suppl.LBA6008","article-title":"Avelumab in patients with gestational trophoblastic tumors resistant to monochemotherapy: Final outcomes of TROPHIMMUN phase II trial, cohort A","volume":"38","author":"You","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/ijgc-2020-001784","article-title":"Fertility and pregnancy outcome in gestational trophoblastic disease","volume":"31","author":"Joneborg","year":"2021","journal-title":"Int. J. Gynecol. Cancer."},{"key":"ref_75","first-page":"531","article-title":"Early pregnancy outcomes after chemotherapy for gestational trophoblastic tumor","volume":"49","author":"Matsui","year":"2004","journal-title":"J. Reprod. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"101974","DOI":"10.1016\/j.eclinm.2023.101974","article-title":"Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: A multicenter, retrospective study","volume":"59","author":"Wang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1471-0528.2003.02388.x","article-title":"Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy","volume":"110","author":"Sebire","year":"2003","journal-title":"BJOG"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1093\/humrep\/dev169","article-title":"Risk of recurrent molar pregnancies following complete and partial hydatidiform moles","volume":"30","author":"Eagles","year":"2015","journal-title":"Hum. Reprod."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Piergentili, R., Sechi, S., De Paola, L., Zaami, S., and Marinelli, E. (2025). Building a Hand-Curated ceRNET for Endometrial Cancer, Striving for Clinical as Well as Medicolegal Soundness: A Systematic Review. Noncoding RNA, 11.","DOI":"10.3390\/ncrna11030034"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1200\/JCO.22.01885","article-title":"Cancer Treatment-Related Ovarian Dysfunction in Women of Childbearing Potential: Management and Fertility Preservation Options","volume":"41","author":"Reynolds","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejogrb.2011.11.011","article-title":"Timing of fertility preservation procedures in a cohort of female patients with cancer","volume":"160","author":"Jenninga","year":"2012","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_82","unstructured":"Kufe, D.W., Pollock, R.E., Weichselbaum, R.R., Bast, R.C., Gansler, T.S., Holland, J.F., and Frei III, E. (2025, July 14). Histopathologic Classification of GTD, Holland-Frei Cancer Medicine, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK13058\/."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Slim, R., and Wallace, E.P. (2013). NLRP7 and the Genetics of Hydatidiform Moles: Recent Advances and New Challenges. Front. Immunol., 4.","DOI":"10.3389\/fimmu.2013.00242"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41379-018-0031-9","article-title":"The genetics of recurrent hydatidiform moles: New insights and lessons from a comprehensive analysis of 113 patients","volume":"31","author":"Nguyen","year":"2018","journal-title":"Mod. Pathol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1642\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:43:19Z","timestamp":1760035399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":84,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medicina61091642"],"URL":"https:\/\/doi.org\/10.3390\/medicina61091642","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]}}}